Literature DB >> 8597051

The use of neurobehavioural test batteries for research, diagnosis and screening: methodological aspects.

A Spurgeon1.   

Abstract

In recent years neurobehavioural tests have been used increasingly in occupational and environmental settings to identify changes in cognitive functioning associated with exposure to neurotoxicants. Applications in cross-sectional research studies, involving the comparison of the performance of exposed and control groups, are relatively well established. However, the use of such methods requires attention to a variety of methodological issues including aspects of study design such as sample size, the selection of appropriate controls, the separation of acute and chronic effects and control or adjustment for numerous potential influences on performance. Studies requiring repeated testing, such as longitudinal investigations or studies of acute effects require attention to learning and practice effects and diurnal rhythms. The validity of adapting existing test batteries for use as diagnostic or screening instruments is questionable. Well-developed techniques exist for diagnosis but this requires lengthy and skilled test administration and interpretation and cannot be accomplished using research batteries. Existing tests may, in the future, be used for screening, but a number of problems will need to be addressed before they can be successfully applied in this context.

Mesh:

Year:  1995        PMID: 8597051     DOI: 10.1016/0378-4274(95)03477-3

Source DB:  PubMed          Journal:  Toxicol Lett        ISSN: 0378-4274            Impact factor:   4.372


  2 in total

1.  Role of human neurobehavioural tests in regulatory activity on chemicals.

Authors:  R Stephens; P Barker
Journal:  Occup Environ Med       Date:  1998-03       Impact factor: 4.402

Review 2.  Prenatal methylmercury exposure and developmental outcomes: review of the evidence and discussion of future directions.

Authors:  Anne Spurgeon
Journal:  Environ Health Perspect       Date:  2006-02       Impact factor: 9.031

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.